---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-043743"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2023-12-05T23:59:59+00:00"
generated_at: "2026-06-07T17:59:07.774138+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Processa Pharmaceuticals presents at MedInvest Oncology Conference on Dec 5, 2023

## Summary
- Dr. David Young, President R&D, presents virtually at MedInvest Oncology Conference on Dec 5, 2023.
- Presentation titled 'Next Generation Chemotherapy: Improved Treatment for More Patients' at 1:35 PM PT/4:35 PM ET.
- CEO George Ng attends in person and is available for Q&A and one-on-one meetings.
- Presentation uploaded to investor portal and made available on Processa's website.

## SEC filing metadata
- accession: 0001493152-23-043743
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2023-12-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315223043743/0001493152-23-043743-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315223043743/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-043743
- JSON: https://secwatch.observer/filing/0001493152-23-043743.json
- Plain text: https://secwatch.observer/filing/0001493152-23-043743.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.